SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today that Dr. Avtar Dhillon, president and CEO, will make a presentation about the company at the BIO International Convention in San Diego, California. The presentation, part of the BIO Business Forum in the “Vaccines” category, will take place at 2:00 p.m. on Thursday, June 19th, in room 5B.
